4.7 Article

Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skin

期刊

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
卷 135, 期 3, 页码 712-720

出版社

MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2014.11.017

关键词

Atopic dermatitis; allergic contact dermatitis; patch testing; T-cell polarization; human skin; nickel; rubber; fragrance

资金

  1. National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [5UL1RR024143-02]
  2. NIH Roadmap for Medical Research
  3. Dermatology Foundation Physician Scientist Career Development Award
  4. CTSA grant from Rockefeller University [UL1 TR000043]
  5. American Dermatological Association's Medical Student Fellowship
  6. NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER
  7. NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Background: Atopic dermatitis (AD) is the most common inflammatory disease. The prevalence of allergic contact dermatitis to allergens (eg, fragrance) is higher in patients with AD, despite a trend toward weaker clinical allergic contact dermatitis reactions. The role of the AD skin phenotype in modulating allergic sensitization to common sensitizers has not been evaluated. Objective: We sought to investigate whether patients with AD have altered tissue immune responses on allergen challenge. Methods: Gene expression and immunohistochemistry studies were performed on biopsy specimens from 10 patients with AD and 14 patients without AD patch tested with common contact allergens (nickel, fragrance, and rubber). Results: Although 1085 differentially expressed genes (DEGs) were commonly modulated in patch-tested skin from patients with AD and patients without AD versus control skin, 1185 DEGs were uniquely altered in skin from patients without AD, and only 246 DEGs were altered in skin from patients with AD. Although many inflammatory products (ie, matrix metalloproteinase 12/matrix metalloproteinase 1/S100A9) were upregulated in both groups, higher-magnitude changes and upregulation of interferon responses were evident only in the non-AD group. Stratification by allergen showed decreased expression of immune, T(H)1-subset, and T(H)2-subset genes in nickel-related AD responses, with increasedT(H)17/IL-23 skewing. Rubber/fragrance showed similar trends of lesser magnitude. Negative regulators showed higher expression in patients with AD. Conclusions: Through contact sensitization, our study offers new insights into AD. Allergic immune reactions were globally attenuated and differentially polarized in patients with AD, with significant decreases in levels of T(H)1 products, some increases in levels of T(H)17 products, and inconsistent upregulation in levels of T(H)2 products. The overall hyporesponsiveness in skin from patients with background AD might be explained by baseline immune abnormalities, such as increased T(H)2, T(H)17, and negative regulator levels compared with those seen in non-AD skin.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

Characterization of a novel non-steroidal glucocorticoid receptor agonist optimized for topical treatment

Stefan Eirefelt, Martin Stahlhut, Naila Svitacheva, Martin A. Carnerup, Joel Mauricio Correa Da Rosa, David Adrian Ewald, Troels T. Marstrand, Mikkel Krogh-Madsen, Georg Dunstl, Kevin Neil Dack, Anna Ollerstam, Hanne Norsgaard

Summary: This study describes a selective non-steroidal glucocorticoid receptor (GR) agonist, LEO 134310, for topical use, which is rapidly deactivated in the blood resulting in low systemic exposure and a higher therapeutic index compared with currently used glucocorticoids. The selectivity of LEO 134310 for GR was confirmed within a panel of nuclear receptors, and topical treatment with LEO 134310 in minipigs did not result in significant epidermal thinning.

SCIENTIFIC REPORTS (2022)

Article Allergy

COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab

Benjamin Ungar, Jacob W. Glickman, Alexandra K. Golant, Celina Dubin, Olga Marushchak, Alyssa Gontzes, Daniela Mikhaylov, Giselle K. Singer, Danielle Baum, Nancy Wei, Antonio Sanin, Diana Gruenstein, Mark G. Lebwohl, Ana B. Pavel, Emma Guttman-Yassky

Summary: This study aimed to investigate the hypothesis that targeting Th2 with the IL4Ra-antagonist, dupilumab, could rebalance the Th1/Th2 axis in inflammatory disease patients, potentially leading to attenuated COVID-19 symptoms.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)

Article Dermatology

Analysis of alopecia areata surveys suggests a threshold for improved patient-reported outcomes

Yael Renert-Yuval, Joel Correa da Rosa, Sandra Garcet, Ana B. Pavel, Jennifer Bares, Margot Chima, Jason E. Hawkes, Patricia Gilleaudeau, Mary Sullivan-Whalen, Giselle K. Singer, James G. Krueger, Emma Guttman-Yassky

Summary: This study investigated the utility of two different alopecia areata-targeted questionnaires, and found that the Alopecia Areata Symptom Impact Scale (AASIS) correlated strongly with alopecia areata severity and clinical response. Patients with <= 20% scalp hair loss after treatment reported improvement in multiple quality-of-life items, which may guide clinicians and improve the development of future clinical trials.

BRITISH JOURNAL OF DERMATOLOGY (2022)

Article Biochemistry & Molecular Biology

Profiling the Atopic Dermatitis Epidermal Transcriptome by Tape Stripping and BRB-seq

Tu Hu, Tanja Todberg, Daniel Andersen, Niels Banhos Danneskiold-Samsoe, Sofie Boesgaard Neestrup Hansen, Karsten Kristiansen, David Adrian Ewald, Susanne Brix, Joel Correa da Rosa, Ilka Hoof, Lone Skov, Thomas Litman

Summary: This study used BRB-seq technique to analyze the transcriptome of tape-stripped skin samples from atopic dermatitis patients and healthy controls. An AD signature consisting of genes related to skin barrier and inflammatory response was identified. However, the low and highly variable transcript counts in tape-stripped samples were a limiting factor for epidermal transcriptome profiling.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Editorial Material Biochemistry & Molecular Biology

Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery

Thomas U. Marron, Matthew D. Galsky, Bachir Taouli, Maria Isabel Fiel, Stephen Ward, Edward Kim, David Yankelevitz, Deborah Doroshow, Emma Guttman, Benjamin Ungar, Saurabh Mehandru, Benjamin J. Golas, Daniel Labow, John Sfakianos, Sujit S. Nair, Dimple Chakravarty, Michael Buckstein, Xiaoyu Song, Effi Kenigsberg, Sacha Gnjatic, Brian D. Brown, Joseph Sparano, Ashutosh Tewari, Myron Schwartz, Nina Bhardwaj, Miriam Merad

Summary: Window-of-opportunity trials offer a platform to understand the mechanisms of short-duration pre-surgical therapies, but there is a need for a paradigm shift in trial design, specimen collection, and analysis.

NATURE MEDICINE (2022)

Letter Dermatology

EASI p-EASI: Predicting Disease Severity in Patients with Atopic Dermatitis Treated with Tralokinumab

Jill I. Olydam, Linde E. M. de Wijs, Willem A. Dik, Mads A. Ropke, Joel Correa Da Rosa, Dirk Jan Hijnen

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Article Allergy

Delayed type hypersensitivity reactions to various allergens may differently model inflammatory skin diseases

Ana B. Pavel, Ester Del Duca, Julia Cheng, Jianni Wu, Benjamin Ungar, Yeriel D. Estrada, Carolyn Jack, Catherine Maari, Etienne Saint-Cyr Proulx, Francisco Ramirez-Valle, James G. Krueger, Robert Bissonnette, Emma Guttman-Yassky

Summary: The treatment of inflammatory skin diseases needs experimental models of skin inflammation in humans to predict treatment effects. In this study, four common sensitizers were administered to healthy patients, and it was found that diphencyprone induced the strongest immune response and best modeled the barrier defects characteristic of atopic dermatitis and psoriasis.

ALLERGY (2023)

Letter Allergy

The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients

Benjamin Ungar, Susan Hartzell, Daniel Lozano-Ojalvo, Sabrina Ghalili, Swaroop Bose, Alexandra K. Golant, Kathryn Tan, Yeriel D. Estrada, Giselle K. Singer, Ana B. Pavel, Paolo Cravedi, Emma Guttman-Yassky

ALLERGY (2023)

Letter Dermatology

Use of dynamic optical coherence tomography in a corticosteroid vasoconstrictor assay: a pilot study

Shayan Owji, Helen He, Joseph Han, Peter Baek, Daniel Yassky, Nicholas Gulati, Benjamin Ungar, Jonathan Ungar

INTERNATIONAL JOURNAL OF DERMATOLOGY (2023)

Article Dermatology

Unique protein signatures evolve during the course of a delayed-type hypersensitivity reaction in human skin

Joseph Han, Scott Stratman, Jade N. Young, Dina Poplausky, Shayan Owji, Yen Luu, Yeriel Estrada, Joel Correa da Rosa, James G. Krueger, Nicholas Gulati

Summary: Diphencyprone (DPCP) causes a delayed-type hypersensitivity reaction when applied topically, and is used clinically for various conditions. In this study, proteomic analysis of healthy volunteers showed upregulation of immune cell activation, tissue remodeling, antineoplastic markers, and Th1 axis markers following DPCP application. Negative regulators of immune function were also upregulated, which may explain the therapeutic benefits in autoimmune conditions. The study also revealed a transient Th2 response followed by Th1 polarization. Overall, DPCP induces a complex and evolving immunological response.

JOURNAL OF DERMATOLOGY (2023)

Article Dermatology

Assessment of Spatial and Temporal Variation in the Skin Transcriptome of Atopic Dermatitis by Use of 1.5 mm Minipunch Biopsies

Tu Hu, Tanja Todberg, David Adrian Ewald, Ilka Hoof, Joel Correa da Rosa, Lone Skov, Thomas Litman

Summary: The skin transcriptome of atopic dermatitis (AD) is stable over time, with the largest variation due to disease, individual, and skin site. AD-specific differentially expressed genes revealed disrupted skin barrier and activated immune response as the main features of AD. Potential novel targets in AD were also identified. This study provides new methods and insights for future skin research.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2023)

Article Allergy

Age of onset defines two distinct profiles of atopic dermatitis in adults

Paola Facheris, Joel Correa Da Rosa, Angel D. D. Pagan, Michael Angelov, Ester Del Duca, Grace Rabinowitz, Pedro Jesus Gomez Arias, Camille Rothenberg Lausell, Yeriel D. D. Estrada, Swaroop Bose, Mashkura Chowdhury, Avner Shemer, Ana B. B. Pavel, Emma Guttman-Yassky

Summary: The unique characteristics of adult-onset atopic dermatitis (AOAD) compared to pediatric-onset AD persisting into adulthood (POAD) have not been well-studied, hindering the development of targeted therapeutics. This study analyzed skin and blood samples from AOAD, POAD, and healthy controls and found that both AOAD and POAD showed immune and barrier dysregulations with shared Th2/Th22 hyperactivation. POAD had greater inflammation and compromised epidermal barrier compared to AOAD. AOAD also had more dysregulated proteins in serum, including pro-inflammatory and cardiovascular-risk markers.

ALLERGY (2023)

Letter Dermatology

Alopecia areata is associated with increased genetic risk of myocardial infarction: A Mendelian randomization study

Ross O'Hagan, Stella A. Caldas, Joel Correa M. da Rosa, Emma Guttman-Yassky, Benjamin Ungar

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Article Biotechnology & Applied Microbiology

The Application of Spearman Partial Correlation for Screening Predictors of Weight Loss in a Multiomics Dataset

Joel Correa da Rosa, Jose O. Aleman, Jason Mohabir, Yupu Liang, Jan L. Breslow, Peter R. Holt

Summary: Obesity is a growing epidemic in the United States, and there is limited understanding of the mechanisms behind weight gain and loss. Integrating omics data has become a popular method to increase understanding of complex phenotypes. The study developed a strategy to screen predictors from a small cohort of obese women, and successfully identified baseline fecal bile acids and regulation in RT-polymerase chain reaction as the most predictive data sources for forecasting weight loss rates.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2022)

Letter Allergy

The impact of dupilumab treatment on severe acute respiratory syndrome coronavirus 2-coronavirus disease 2019 antibody responses in patients with atopic dermatitis

Benjamin Ungar, Leore Lavin, Alexandra K. Golant, Alyssa Gontzes, Eden David, Yeriel D. Estrada, Giselle K. Singer, Ana B. Pavel, Emma Guttman-Yassky

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2022)

暂无数据